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curative (definitive or preoperative) therapeutic intent reported 
significant toxicity. To enable full interpretation of outcome toxicity 
data, both the specific tumor type and the related disease site being 
irradiated will require both to be specified as study eligibility criteria, 
together with a description of detailed radiation dose-volume 
dependencies within the treatment protocol. This will also facilitate 
identification of adverse radiation effects that are separate from toxic 
effects of the systemic agent. In addition to determining treatment 
safety, proof of biological activity and – ideally – target-dependent 
radiosensitizing ability of the investigational agent should be regarded 
as a study objective. Finally, if the study eligibility criteria employ 
the principles of defining both the tumor type and anatomic location 
of the specific target volume being treated, the resultant 
homogeneous patient population will also ultimately enable treatment 
response evaluation. 
   
 SYMPOSIUM: INACCURACIES AND NEAR MISSES IN 
RADIOTHERAPY AND HOW TO ADDRESS THEM  
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Synoptic reporting and analysis of incidents in radiotherapy, and 
elsewhere in medicine, means being directed to providing key 
descriptive information in a structured format. There are three 
principal advantages of synoptic reporting: completeness, lack of 
ambiguity and searchability. Firstly, the reporting and analysis forms, 
if well designed, will ensure that all key information required to 
understand the incident and to develop corrective actions is recorded. 
This meets the requirement of completeness. The problem of 
ambiguity can, to some extent, be mitigated by restricting responses 
to key elements of the report and analysis to predetermined lists of 
options with carefully thought out language. The third benefit of 
structured synoptic reporting is that the databases into which reports 
and analyses are entered can be rapidly searched and hence major 
issues flagged and trends identified. Additional flexibility is included 
in an incident learning system through incorporating free text boxes 
where the reporter and analyst can augment the basic information 
entered. 
The presentation will commence with an overview of a generic 
incident learning system and will then introduce SAFRON and the U.S. 
national incident reporting initiative as examples of the 
implementation of such systems. The structure of these will be 
discussed identifying the synoptic and free text components. To 
understand where in the radiotherapy process the incident originated 
and where it was discovered process maps are used. The severity of 
an incident, which often determines the priority of the response and 
corrective actions, is an important component of the synopsis 
although severity can be hard to establish particularly as the 
consequences of a clinical RT incident may not be apparent for weeks 
or months. In order to implement effective corrective actions it is 
important that they follow from the identification of basic 
causes/contributing factors. The approaches of SAFRON and the U.S. 
implementation will be discussed in the context of these three 
synoptic elements. 
As well as enhancing the quality and safety of radiotherapy, properly 
constructed incident learning systems can also help us to identify the 
most effective impediments to error propagation. Both SAFRON and 
the US system specifically include safety barriers in the synoptic 
reporting structure. The reporter/analyst is invited to identify those 
barriers which the error penetrated and that barrier at which the 
error was stopped. 
Synoptic reporting aids clear communication and analysis of 
radiotherapy incidents. It can also guide the development of an 
efficient safety program by discriminating between more effective 
and less effective safety barriers. 
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Following the death of her son as a result of medical error, the 
focusof Margaret’s work relates to seeing adverse events as having the 
potential tobe catalysts for change as well as being opportunities for 
learning, identifying areas for improvement and preventing 
recurrence.  
During her presentation she will provide a case study highlighting the 
gaps between the patient safety measures possible and those actually 
being experienced by patients (communication, record-keeping, 
diagnosis and test results, handovers, transitions in care, responding 
to the deteriorating patient, practising truly patient centred care). 
She will also discuss: 
· The case for involvement of patient and family in assuring safe care. 
· The need to demonstrate professionalism in the aftermath of 
adverse events – transparency, disclosure, learning and preventing 
recurrence. 
· The patient experience of care and the students’ response to being 
exposed to that reality - the power of the story. 
· The role of education in creating sustainableculture change. 
She will offer some reflections on nuclear medicine from a patient 
perspective and propose the WHO Patients for Patient Safety 
collaborative/partnership model as a patient safety solution. 
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Purpose: This lecture will present the actual scenario of contouring 
standards in Radiotherapy and how a correct segmentation of target 
and organs at risk grant a reliable treatment plan.  An overview of all 
the anatomical districts will be offered together with a deepening in 
the delineation quality indicators, defined as contours adherence to 
International or Institutional Guidelines. 
Method and materials: Different techniques and technologies such as 
high definition morpho/biological imaging, contouring atlases with or 
without tutorial purposes, different rigid and deformable 
commercially available coregistration softwares with autocontouring 
features have been presented in order to explore their role in gaining 
adequate standards in contouring procedures.  
A brief overview of the main similarity indexes has been offered too. 
Results: An adequate quality assurance in contouring is mandatory to 
grant a reliable treatment plan: in order to check the adherence of 
contours proposed by a manual delineator or by an autosegmentation 
software to adopted guidelines indexes, such as the Dice Similarity 
Index can be calculated, also for tutorial purposes. 
Conclusions: Modern Radiotherapy (RT) can deliver high dose rates to 
extremely small volumes and high precision RT could mean significant 
dosimetrical error due to a unfitting dose coverage or to a systemic 
error caused by inappropriate contouring.  
Modern technologies can help in maintaining adequate contouring 
standards but an Indipendet Check (IC) by skilled operators of the 
proposed structures remains mandatory. 
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Serious radiotherapy accidents have been notified in France in 2005 
and 2006 (Epinal, Toulouse). The main identified causes were 
organisational and human factors. In response, a national action plan, 
later part of the national cancer plan 2009-2013, was implemented by 
the Health Ministry between 2007 and 2012. INCa (French National 
Cancer Institute) was in charge of managing the national action plan 
which involved several stakeholders, including radiation oncologist 
and medical physicist societies.The national action plan was based on 
33 national measures spread across seven fields as the quality and 
safety of the practices, the vigilance in radiotherapy, the human 
resources and training, the safety of facilities, the relationship with 
patients and the public, the strengthening of ASN’s inspections and 
the monitoring and knowledge of the discipline. In addition to  its 
inspection program, ASN has led 3 national radiotherapy measures : 
 publication of a set of radiotherapy quality requirements and a 
strengthening of the regulations specifying the quality assurance 
(QA) obligations, including risk analysis ;  
 publishing of guidelines for professionals on the notification of 
significant radiation protection events (SRPE) ;  
 creation of an incident scale rating for the purposes of 
communicating to the public.  
Since 2008, each year, ASN publishes the main findings of its 
inspection program in radiotherapy, stressing on the progressive 
improvement of safety treatments. Reports on SRPE, presenting the 
main causes of the events, are also put on ASN website. The increase 
of the number of notified events since 2008 demonstrates the 
improvement of safety culture, most of notified events being without 
any consequences to the health of patients. The feedback experience 
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is organised at national level, in close collaboration between ASN and 
radiotherapy professionals, leading to the publication of newsletters 
about the safety of patients. 
Taking into account one of the main findings of the international 
conference on Modern Radiotherapy, organised in 2009, by ASN, in 
Versailles (France), the European Commission decided to strengthen 
the European Basic Safety Standard introducing new requirements 
related to events reporting and risk analysis, and to launch the 
ACCIRAD project led by the Greater Poland Cancer Centre (GPCC, 
Poland)[1], following the goal to issue an European guidance on these 
topics in 2013. A general questionnaire sent to member states in 2012 
showed that more than half EU countries have already implemented in 
their legal system a requirement for risk analysis in radiotherapy, and 
classification, recording and reporting of adverse events and near 
misses. However, despite 15 years passed since 1997, in many EU 
countries the requirement for a legal framework regarding risk 
analysis and event’s classification, recording and reporting systems 
was not addressed and the practical implementation of the systems 
was still incomplete.A 2nd questionnaire, still being analysed, should 
allow to identify pertinent risk analysis methodologies used by 
radiotherapy centres and also good practices for event’s 
classification. On this basis, recommendations will be prepared by the 
ACCIRAD consortium to be included in the European guidance. The 
first results of these on going works will be presented at the  Geneva 
ESTRO conference in April 2013. 
   
 SYMPOSIUM: ADVANCED METHODS FOR TOXICITY 
PREDICTIVE MODELS  
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Characterising the dose-volume response of normal tissue structures is 
an important part of optimising radiotherapy treatment planning. 
However, understanding how the dose-distribution to a structure is 
related to outcome is confounded by co-morbidities and combinations 
of treatments as well as incomplete and inconsistent data.  One 
approach to this challenge is Machine Learning.  Machine learning 
describes models which learn from examples of a specific data type 
without a priori information about the relationship between the data.  
When both input variables and the corresponding outcome data are 
available, this known as supervised learning.  Once the relationship 
has been inferred it is possible to make prediction for previously 
unseen cases. 
The published literature on the use of machine learning approaches to 
model dose-volume effects utilise different algorithms.  Two 
commonly used supervised learning approaches are Artificial Neural 
Networks and Support Vector Machines. 
Artificial Neural Networks (ANN) are a (simplified) mathematical 
analogy of learning in the brain.  An ANN is trained by presenting 
example datasets to the network.  Input variables are propagated 
through a network of interconnected nodes and compared to the 
known outcome.  The weights of the connections between the nodes 
are altered iteratively so that the outcome is predicted correctly from 
the input data. 
Support vector machines (SVM) are used for dichotomised outcomes 
e.g. toxicity/no toxicity.  Separation between the two possible classes 
is achieved by translating the input variables in to a high-dimensional 
feature space where a boundary is derived to maximise the separation 
between the classes.    
An important consideration when developing a machine learning-based 
model is how to represent the input data.  This issue is not unique to 
machine learning and is also relevant to conventional statistical 
approaches.   When trying to predict radiation-induced toxicity the 
dose distribution to relevant structures need to be included. 
 Generally this is achieved by using summary measures such maximum 
dose and mean dose to the structure.  The dose-volume histogram can 
be reduced to a summary measure such as Equivalent Uniform Dose 
(EUD).  Often sequential variables describing the volume of the 
structure receiving a specified dose eg V5, V10, V15 etc are included.  
 A more detailed approach is to include a spatial description of the 
dose.  These dosimetric features will be combined with clinical 
information and information regarding other therapies such as 
chemotherapy. 
A successful model will be able to make predictions for previously 
unseen data.  Cross validation, where models are built on subsets of 
available data and tested and validated on independent samples, can 
ensure the ability of a model to generalise.  The effect of each 
variable on the ability of a model to make accurate predictions can be 
assessed with methods such as “leave one out” which as suggested 
repeats the process without a variable and assess the effect. 
This presentation will provide an overview of published literature on 
the modelling of dose-volume effects using machine learning.   A 
worked example of both ANN and SVM approaches to predict acute 
toxicity following head and neck radiotherapy will be used to 
demonstrate methodology.  The results will also be compared to a 
conventional multivariable analysis.   
Relatively little has been published on the use of machine learning 
approaches to the modelling of dose-volume effects.  However, they 
provide a complementary alternative to conventional statistical 
techniques. Consequently there is potential to further our 
understanding of the relationship between the dose distribution to a 
normal structure and corresponding radiation-induced toxicity. 
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It is well known that the risk of radio-induced toxicity increases when 
higher doses and larger volumes are involved in the irradiation and, in 
the last years, some consistent results have been published on the 
possible estimation of normal tissue complication probability (NTCP) 
for a number of organs-at-risk. The widespread method used for such 
calculations is based on a sigmoid dose-response curve coupled to 
reduction of the whole dose-volume histogram into one parameter 
(such as the equivalent uniform dose).  
NTCP models with their prediction based only on dosimetric variables 
can be used in treatment planning and can act as a baseline 
reference.  
On the other hand, it is becoming clearer that radiation-related side 
effects are also correlated to a number of patient-related factors. 
With the advent of newer radiotherapy technologies, which allow 
steep gradients and minimization of doses to normal tissues, there is 
an increased interest in understanding clinical/genetic risk factors 
that might enhance patient radio-sensitivity and to develop NTCP 
models which might include these variables in order to achieve better 
normal tissue complication predictions.  
Some recently published studies have shown that current NTCP models 
can be improved by incorporating clinical risk factors into model 
formulation. Overview of published results will be presented. 
A further important step is the inclusion of molecular/genetic 
predictors into NTCP models. This issue is still at a very primitive 
stage  and should be elucidated because, given the same set of 
clinical/dosimetric factors, patient-to patient variability in normal 
tissue response to radiation has been widely recognized in clinical 
practice, suggesting that this phenomenon might be, at least in part, 
genetically driven. 
In this presentation data on molecular/genetic markers influencing 
radio-induced toxicity are presented, together with the first findings 
supporting the hypothesis that a genetically determined dose–response 
relationship is possible and could be used to predict the probability of 
side effects associated with radiotherapy and serve as a rational basis 
for individualized radiation dose prescriptions. 
The future lies in these multi-factorial prediction models: a great 
effort has to be done to collect reliable detailed prospective data for 
the development of NTCP models with the inclusion of predisposing 
clinical/geneticfeatures for normal tissues involved in radiotherapy. 
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Trismus, which results in difficulty, restriction or pain when opening 
the mouth (CTCAE), is a common complication in head and neck 
cancer patients following radiotherapy and leads to degradation in 
quality of life. There are few studies that have addressed radiation 
induced trismus. However, the main cause remains poorly understood. 
Studies have attributed trismus to the irradiation of a range of organs 
at risk (OAR) such as the mastication muscles, the temporomandibular 
joint (TMJ), and pterygoid plate among others.  
